Aug 7, 2026 04:05PM
Aug 3, 2026 07:00AM
Jul 9, 2026 04:05PM
Jul 1, 2026 07:00AM
Jun 22, 2026 04:05PM
Jun 22, 2026 06:59AM
Jun 17, 2026 08:45AM Ocular Therapeutix plans wet AMD drug filing for late 2026
Jun 17, 2026 08:45AM
Jun 5, 2026 07:00AM
Jun 4, 2026 07:00AM
Jun 2, 2026 07:00AM
May 15, 2026 07:00AM
May 8, 2026 04:05PM
May 5, 2026 07:00AM Ocular Therapeutix™ Reports First Quarter 2026 Financial Results and Business Highlights
Apr 29, 2026 07:00AM
Apr 29, 2026 07:00AM
Apr 28, 2026 07:00AM
Apr 27, 2026 07:00AM
Apr 22, 2026 07:00AM
Apr 19, 2026 10:00AM
Apr 14, 2026 07:00AM Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apr 13, 2026 07:01AM
Apr 13, 2026 07:00AM
Apr 1, 2026 07:00AM
Mar 9, 2026 04:01PM
Feb 24, 2026 07:00AM
Feb 23, 2026 07:00AM
Feb 20, 2026 07:53AM Ocular Therapeutix (OCUL) PT Lowered to $18 at Needham
Feb 19, 2026 02:01PM
Feb 17, 2026 07:02AM
Feb 17, 2026 07:00AM
Feb 13, 2026 05:00PM
Feb 13, 2026 05:00PM
Feb 6, 2026 04:01PM
Feb 5, 2026 08:55AM RBC Capital on Ocular Therapeutix (OCUL): Weakness a Buying Opportunity
Feb 5, 2026 07:00AM
Jan 23, 2026 04:01PM
Jan 21, 2026 07:00AM
Jan 21, 2026 07:00AM
Dec 9, 2025 04:00AM
Dec 8, 2025 07:02AM
Dec 8, 2025 07:00AM Ocular Therapeutix™ Announces Plans to Accelerate NDA Submission Timeline for AXPAXLI™ in Wet AMD
Dec 8, 2025 06:46AM
Dec 8, 2025 05:08AM
Dec 8, 2025 04:34AM
Dec 5, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 24, 2025 07:00AM
Nov 12, 2025 07:00AM Ocular Therapeutix™ to Participate in November and December Investor Conferences
Nov 7, 2025 07:00AM

328,151 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All